MAZEMaze Therapeutics Inc. Common Stock
29.43USD+1.73%Mkt Cap: 1.63B $P/E: —3d ago
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.63B $
Enterprise Value1.26B $
Revenue (TTM)20.00M $
Gross Profit20.00M $
Net Income (TTM)-131.12M $
Revenue/Share0.3770 USD
Last Price29.43 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees141
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.11
PEG—
EV/EBITDA-8.74
EV/Revenue62.82
P/S80.35
P/B3.54
EPS (TTM)-2.37
EPS (Forward)-3.18
52W Range
12.9141% of range53.65
52W High53.65 USD
52W Low12.91 USD
Profitability
Gross Margin100.00%
Oper. Margin-728.06%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-36.94%
ROA-33.02%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.94M $
CapEx (TTM)794.00K $
FCF Margin-318.14%
FCF Yield-3.89%
Net Debt-350.66M $
Net Debt/EBITDA2.44
Balance Sheet
Debt/Equity0.07
Current Ratio18.31
Quick Ratio18.03
Book Value/Sh8.164 USD
Cash/Share7.400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)62.55 USD
Upside (mean)+112.5%
Target Range46.00 USD – 110.00 USD
$46.00+112.5% to mean$110.00
# Analysts11
Ownership
Shares Out.55.55M
Float36.77M
Insiders1.46%
Institutions106.74%
Short Interest
Short Ratio11.2d
Short % Float11.56%
Short % Out.10.26%
Shares Short5.68M
Short (prev mo.)5.53M
Technical
SMA 5028.02 (+5.0%)
SMA 20034.41 (-14.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)370.16K
Avg Vol (10d)416.34K
Technical Indicators
RSI (14)57.2
MACD0.2195
MACD Signal0.0134
MACD Hist.+0.2061
BB Upper29.67 USD
BB Middle28.02 USD
BB Lower26.38 USD
BB Width11.76%
ATR (14)1.451 USD
Vol Ratio (20d)0.75x